There is good news for those with acute pain, as the FDA has approved a first-of-its-kind pain medication, and it’s one ...

The pooled prevalence of chronic painful neuropathy is 41.22% among individuals with chemotherapy-induced peripheral neuropathy (CIPN).

A new study suggests popular weight-loss drugs like Ozempic and Zepbound may be linked to rare eye conditions that could ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

There is currently no known cure for neuropathy, and most treatments address acute symptoms with no lasting impact," says Dr.

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

Vincristine is a commonly used chemotherapy drug in the treatment of pediatric acute lymphoblastic leukemia ... as vincristine-induced peripheral neuropathy (VIPN), which can significantly ...

The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid ...

The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway out of the eye is too small, she explained. This could happen when glucose ...